Feedback / Questions
BOLD-100 - Intezyne, Bold Therap
https://www.prnewswire.com/news-releases/bold-therapeutics-extends-south-korea-option-agreement-for-bold-100-a-first-in-class-anti-resistance-therapeutic-301460182.html
Jan 13, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next